BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Gene therapy is entering a defining new chapter. After a perio
 d of challenge and recalibration\, the field is regaining momentum\, driv
 en by teams who remain steadfast in their belief that this science can tr
 ansform lives. Confidence is returning\, with significant investments and
  acquisitions signalling a renewed commitment to overcoming barriers of s
 afety\, efficacy\, and scalability.\n\nThe 9th Gene Therapy Development S
 ummit returns to Boston as the meeting point for this community. Join 100
 + leading voices from the likes of Bayer\, Astellas Pharmaceuticals\, REG
 ENXBIO\, Ocugen\, AskBio\, CureDuchenne Ventures\, and more to come toget
 her to share ideas\, restore confidence\, and chart a sustainable path fo
 rward for gene therapy.\n\nConnect with your peers in pre-clinical develo
 pment\, manufacturing\, analytical development\, clinical operations\, an
 d regulatory affairs for an unrivalled learning and networking opportunit
 y across the end-to-end of gene therapy development.\n\nDate and Time: Tu
 esday\, 24 March 2026 at 08:00 - Thursday\, 26 March 2026 at 18:00\n
DTEND:20260326T180000
DTSTAMP:20260416T145652Z
DTSTART:20260324T080000
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, Massach
 usetts\, 02116\,
SEQUENCE:0
SUMMARY:Gene therapy is entering a defining new chapter. After a period of
  challenge and recalibration\, the field is regaining momentum\, driven b
 y teams wh...
UID:fb781f3a-44d7-42dd-875e-f0f5f06dc672
END:VEVENT
END:VCALENDAR